The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
The FDA has also initiated rulemaking to eliminate the 1997 "adequate provision" loophole, which allowed companies to include a "major-risk statement" and then direct viewers to a website, toll-free ...
The director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...
The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results